Combined Oral Contraceptives in Migraine Without Aura
Yes, combined oral contraceptives (COCs) can be prescribed to patients with migraine without aura, provided they have no additional arterial risk factors 1, 2.
Key Decision Algorithm
The prescription decision hinges on a two-step assessment:
Step 1: Confirm Migraine Subtype
- Migraine WITHOUT aura = COCs are permissible
- Migraine WITH aura = COCs are absolutely contraindicated 1, 2
Step 2: Screen for Additional Arterial Risk Factors
If ANY of the following are present, COCs are contraindicated even in migraine without aura 1, 2:
- Age ≥35 years AND smoking (especially >15 cigarettes/day)
- Hypertension (except history of gestational hypertension only)
- Personal history of arterial events (stroke, MI)
- Family history of premature cardiovascular disease (before age 50)
- Diabetes with complications or multiple risk factors
- Other cardiovascular risk factors in combination
Evidence-Based Rationale
The most recent guideline evidence 2 from 2025 explicitly states that in women with migraine without aura, CHC can be prescribed in the absence of any other arterial risk factor. This is reinforced by the French Society of Endocrinology guidelines 1, which note that "the decision tree is identical for women with migraine" as for those with cardiovascular disease history.
Understanding the Stroke Risk
The stroke risk profile differs critically by migraine subtype:
- Migraine with aura alone: 2.7-fold increased stroke risk 3
- Migraine with aura + COCs: 6.1-fold increased stroke risk 3
- Migraine without aura + COCs: 1.8-fold increased stroke risk 3
- Migraine without aura alone: 2.2-fold increased stroke risk 3
Importantly, COCs do not substantially further increase stroke risk in women with migraine without aura beyond the baseline migraine risk itself 3. The absolute incidence remains low at 11 strokes per 100,000 women of reproductive age 3.
The most recent 2026 Japanese study 4 found no significant increase in ischemic stroke risk with low-dose COCs (20-35 μg estrogen) in women with migraine, with a hazard ratio of 0.10 (95% CI: 0.01-1.36), though this study did not separate by aura status.
Critical Pitfalls to Avoid
Failing to distinguish aura status: Always explicitly ask about visual disturbances, sensory symptoms, or speech difficulties that develop gradually over 5-60 minutes before headache onset. If aura is present or uncertain, COCs are contraindicated 2, 5.
Missing new-onset aura: If a patient on COCs develops aura symptoms for the first time, discontinue COCs immediately 5.
Overlooking cumulative risk factors: A 34-year-old with migraine without aura who smokes may technically qualify for COCs, but this represents borderline risk that warrants serious consideration of progestin-only alternatives 1.
Ignoring blood pressure: Measure blood pressure before any COC prescription, even without hypertension history 1.
Alternative Options
When COCs are contraindicated or borderline, recommend:
- Progestin-only pills (can be used regardless of migraine type or risk factors) 1, 2
- Levonorgestrel implant 1
- Progestin IUD 1
- Non-hormonal methods 2
These progestin-only methods carry no increased stroke risk and may actually improve migraine outcomes in some patients 6.